TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Zai Lab stock rallies on regulatory optimism in China’s oncology sector Zai Lab stock jumps 7.6% on China FDA review optimism for its oncology drugs, as cross-border biotech sentiment improves. Read the full investor analysis. byPallavi MadhirajuMay 17, 2025